Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine iliofascial block in total hip arthroplasty
ChiCTR2500109789Phase 4Recruiting
- Sponsor
- Enshi City Center Hospital
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in hip fracture and hip osteoarthritis (2 arms), sponsored by Enshi City Center Hospital. Primary endpoints: Evaluation of postoperative analgesia and Evaluation of muscle strength after operation. Started Sep 2025; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
hip fracturehip osteoarthritis
Beyond the preview
Go deeper on ChiCTR2500109789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109789.